Management of Androgenetic Alopecia in Postmenopausal Women

The document reviewed the management of female androgenetic alopecia (APF) in postmenopausal women, a condition affecting 50% of women and causing significant psychological stress. It discussed the clinical forms of APF, including diffuse, male-pattern, and Christmas-tree pattern, and emphasized the importance of appropriate laboratory tests to rule out other causes of hair loss. The study highlighted the role of the enzyme 5α reductase in the condition's pathophysiology and noted that treatments like minoxidil were primarily used, while finasteride's efficacy in postmenopausal women was questioned. The document also stressed the need for a comprehensive evaluation to exclude other hair loss causes and recommended dietary adjustments and addressing scalp conditions that might hinder treatment effectiveness.